Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Neoplasms 5Thyroid Nodule 3Thyroid Cancer, Papillary 1Carcinoma, Medullary 1

Interventions

Magnetic Resonance Spectroscopy 8Iodine-131 8Thyrotropin Alfa 5trametinib 4selpercatinib 4dabrafenib 4Vemurafenib 4lenvatinib 3cabozantinib 3Sunitinib 3Specimen Handling 3Sorafenib 3Radiofrequency Ablation 3Fluorodeoxyglucose F18 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3vandetanib 2entrectinib 2cobimetinib 2X-Rays 2Trastuzumab 2Thyroid (USP) 2Rosiglitazone 2Radiotherapy 2Nivolumab 2Interviews as Topic 2Gefitinib 2Everolimus 2Bortezomib 2AZD 6244 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thyroid Cancer, Papillary × Thyroidectomy × Clear all
NCT02138214 2020-12-21

Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer

University of Wisconsin, Madison

Phase 2 Completed
117 enrolled 15 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡